首页> 美国卫生研究院文献>Journal of Thoracic Disease >Mid-term follow-up after suture-less aortic heart valve implantation
【2h】

Mid-term follow-up after suture-less aortic heart valve implantation

机译:无缝合主动脉瓣植入术后的中期随访

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAortic stenosis (AS) is the most common valve disease in the adult population and its prevalence increases with age. Unfortunately, older age and comorbidities significantly increase mortality, operative risk and worsen prognosis. In recent years, sutureless bioprosthesis [sutureless-aortic valve replacement (SU-AVR)] has become an alternative to standard AVR or TAVI in high-risk patients. Compared to standard AVR, the advantages of SU-AVR include shorter valve implantation, shorter aortic cross clamp (ACC) and cardiopulmonary bypass (CPB) times and higher valve EOA with more favorable hemodynamic parameters. Good early clinical and hemodynamic outcomes have been reported in several studies. However, although early SU-AVR results reported in the literature are encouraging, there are few results of long term follow-up. The aim of this study is to present long term echocardiographic hemodynamic outcomes of the Enable sutureless bioprosthesis.
机译:背景技术主动脉瓣狭窄(AS)是成年人口中最常见的瓣膜疾病,其患病率随年龄增长而增加。不幸的是,老年和合并症会大大增加死亡率,手术风险并恶化预后。近年来,无缝合生物假体[无缝合主动脉瓣置换术(SU-AVR)]已成为高危患者中标准AVR或TAVI的替代产品。与标准AVR相比,SU-AVR的优势包括较短的瓣膜植入,较短的主动脉交叉钳(ACC)和体外循环(CPB)时间以及较高的瓣膜EOA,以及更有利的血液动力学参数。几项研究已经报道了良好的早期临床和血液动力学结果。然而,尽管文献中报道的早期SU-AVR结果令人鼓舞,但长期随访的结果却很少。这项研究的目的是介绍使能缝合的生物假体的长期超声心动图血流动力学结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号